May 14, 2015 — A new study reports that antiplatelet drug ticagrelor (Brilinta) works faster and is more effective in bl ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
May 12, 2015 — Cardiovascular Systems Inc. (CSI) featured two-year data from its ORBIT II study of the company’s ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
May 11, 2015 — Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth ...
May 8, 2015 — Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the ...
With increased discussion and awareness placed on patient radiation exposure in medical imaging, similar concerns have ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
May 6, 2015 — The Organization for Occupational Safety in Interventional Fluoroscopy (ORSIF) announced the release of a ...
May 6, 2015 — People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent ...
May 4, 2015 — A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
May 4, 2015 — Boston Scientific Corp. is taking a new approach to evaluate the performance of the Vessix Renal ...
May 4, 2015 — Sunshine Heart Inc. announced that the U.S. Food and Drug Administration (FDA) has reviewed the company’s ...
April 30, 2015 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the following late ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
April 30, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental new ...
The long-awaited U.S. Food and Drug Administration (FDA) approval of the first transcatheter left atrial appendage (LAA) ...
April 29, 2015 — COR Medical Technologies (COR) announced that Gregg W. Stone, M.D. has been appointed to its Senior ...
May 14, 2015